Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 86:
87. The compound of claim 85, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2f is 3- to 12-membered heterocyclyl, wherein the 3- to 12-membered heterocyclyl is substituted by 1, 2, 3, 4, or 5 independently selected R2i substituents; and
each R2i is independently C1-C6alkyl, C2-C6 alkynyl, C6-C14 aryl, C(O)R5, C(O)OR5, or S(O)2R5 wherein each C1-C6 alkyl, C2-C6 alkynyl, and C6-C14 aryl is optionally and independently substituted by 1 or more independently selected R4a substituents.